The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).
Hosted on MSN
Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac
Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with ...
A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim trial ...
Patients who had concurrent thrombotic thrombocytopenic purpura (TTP) and COVID-19 had elevated risk of mortality and other complications. Patients who had concurrent thrombotic thrombocytopenic ...
A retrospective database analysis demonstrated the high clinical burden experienced by patients with severe deficiencies of ADAMTS13 and thrombotic thrombocytopenic purpura (TTP)–related diagnoses. In ...
At the Government Kilpauk Medical College (KMC) Hospital, its ‘Red Alert OBG’, a multidisciplinary rapid response team for maternal care, enabled the early diagnosis and prompt treatment of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results